BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22894569)

  • 1. Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis.
    Chen JH; Ou HP; Lin CY; Lin FJ; Wu CR; Chang SW; Tsai CW
    Chem Res Toxicol; 2012 Sep; 25(9):1893-901. PubMed ID: 22894569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.
    Voshavar C; Shah M; Xu L; Dutta AK
    Neurotox Res; 2015 Nov; 28(4):302-18. PubMed ID: 26201265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of seaweeds against 6-hydroxidopamine-induced cell death on an in vitro human neuroblastoma model.
    Silva J; Alves C; Pinteus S; Mendes S; Pedrosa R
    BMC Complement Altern Med; 2018 Feb; 18(1):58. PubMed ID: 29444677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of the pi class of glutathione S-transferase by carnosic acid in rat Clone 9 cells via the p38/Nrf2 pathway.
    Lin CY; Wu CR; Chang SW; Wang YJ; Wu JJ; Tsai CW
    Food Funct; 2015 Jun; 6(6):1936-43. PubMed ID: 25974399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aureusidin ameliorates 6-OHDA-induced neurotoxicity via activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway in SH-SY5Y cells and Caenorhabditis elegans.
    Hu K; Zhu S; Wu F; Zhang Y; Li M; Yuan L; Huang W; Zhang Y; Wang J; Ren J; Yang H
    Chem Biol Interact; 2024 Jan; 387():110824. PubMed ID: 38056806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells.
    Jramne-Saleem Y; Danilenko M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells.
    Meng XB; Sun GB; Wang M; Sun J; Qin M; Sun XB
    Evid Based Complement Alternat Med; 2013; 2013():971712. PubMed ID: 24159358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models.
    Tong H; Zhang X; Meng X; Lu L; Mai D; Qu S
    Front Mol Neurosci; 2018; 11():165. PubMed ID: 29872377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a mouse model expressing a bifunctional glutathione-synthesizing enzyme to study glutathione limitation in vivo.
    Timson RC; Khan A; Uygur B; Saad M; Yeh HW; DelGaudio NL; Weber R; Alwaseem H; Gao J; Yang C; Birsoy K
    J Biol Chem; 2024 Feb; 300(2):105645. PubMed ID: 38218225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction.
    Wu CR; Tsai CW; Chang SW; Lin CY; Huang LC; Tsai CW
    Chem Biol Interact; 2015 Jan; 225():40-6. PubMed ID: 25446857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity.
    Lin CY; Chen JH; Fu RH; Tsai CW
    Chem Res Toxicol; 2014 Nov; 27(11):1958-66. PubMed ID: 25271104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action.
    Mirza FJ; Zahid S; Holsinger RMD
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson's Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway.
    Fu RH; Tsai CW; Liu SP; Chiu SC; Chen YC; Chiang YT; Kuo YH; Shyu WC; Lin SZ
    Antioxidants (Basel); 2022 Oct; 11(11):. PubMed ID: 36358461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosmarinic Acid Attenuates Rotenone-Induced Neurotoxicity in SH-SY5Y Parkinson's Disease Cell Model through Abl Inhibition.
    Han X; Han B; Zhao Y; Li G; Wang T; He J; Du W; Cao X; Gan J; Wang Z; Zheng W
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender.
    Faridzadeh A; Salimi Y; Ghasemirad H; Kargar M; Rashtchian A; Mahmoudvand G; Karimi MA; Zerangian N; Jahani N; Masoudi A; Sadeghian Dastjerdi B; Salavatizadeh M; Sadeghsalehi H; Deravi N
    Front Neurosci; 2022; 16():909833. PubMed ID: 35873824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation.
    Iorio R; Celenza G; Petricca S
    Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson's Disease.
    Rakowski M; Porębski S; Grzelak A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells.
    Lai CY; Lin CY; Wu CR; Tsai CH; Tsai CW
    Front Pharmacol; 2021; 12():703894. PubMed ID: 34434108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrf2 as a potential target for Parkinson's disease therapy.
    Niu Y; Zhang J; Dong M
    J Mol Med (Berl); 2021 Jul; 99(7):917-931. PubMed ID: 33844027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.